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SV40 is a small, non enveloped DNA virus with an icosahedral capsid of 45 nm. The outer shell is composed of pentamers of
the major capsid protein, VP1, linked via their flexible carboxy-terminal arms. Its morphogenesis occurs by assembly of
capsomers around the viral minichromosome. However the steps leading to the formation of mature virus are poorly
understood. Intermediates of the assembly reaction could not be isolated from cells infected with wt SV40. Here we have used
recombinant VP1 produced in insect cells for in vitro assembly studies around supercoiled heterologous plasmid DNA carrying
a reporter gene. This strategy yields infective nanoparticles, affording a simple quantitative transduction assay. We show that
VP1 assembles under physiological conditions into uniform nanoparticles of the same shape, size and CsCl density as the wild
type virus. The stoichiometry is one DNA molecule per capsid. VP1 deleted in the C-arm, which is unable to assemble but can
bind DNA, was inactive indicating genuine assembly rather than non-specific DNA-binding. The reaction requires host
enzymatic activities, consistent with the participation of chaperones, as recently shown. Our results demonstrate dramatic
cooperativity of VP1, with a Hill coefficient of ,6. These findings suggest that assembly may be a concerted reaction. We
propose that concerted assembly is facilitated by simultaneous binding of multiple capsomers to a single DNA molecule, as we
have recently reported, thus increasing their local concentration. Emerging principles of SV40 assembly may help
understanding assembly of other complex systems. In addition, the SV40-based nanoparticles described here are potential
gene therapy vectors that combine efficient gene delivery with safety and flexibility.
Citation: Mukherjee S, Abd-El-Latif M, Bronstein M, Ben-nun-Shaul O, Kler S, et al (2007) High Cooperativity of the SV40 Major Capsid Protein VP1 in
Virus Assembly. PLoS ONE 2(8): e765. doi:10.1371/journal.pone.0000765
INTRODUCTION
SV40, a member of polyomaviradae family, has a small double-
stranded circular DNA genome of 5.2 kb. The DNA is complexed
with histones, forming a nucleosomal structure similar to cellular
chromatin, referred to as a minichromosome. The SV40 structure
has been solved at 3.1 A ˚ resolution [1]. The viral capsid,
surrounding the viral minichromosome, is a T=7d icosahedral
lattice ,45 nm in diameter. It is composed of three viral-encoded
proteins, VP1, VP2, and VP3. VP3 translation initiates from an
internal AUG within the VP2 coding sequence utilizing the same
translational frame. Thus both proteins share 234 identical amino
acids at their carboxy part, and are frequently referred to as VP2/
3. VP1 forms the outer shell while VP2 and VP3 bridge between
the VP1 shell and the chromatin core. The VP1 monomers are
tightly bound in pentamers that are readily formed in the
cytoplasm following mRNA translation, through interdigitating
b-strands [2]. A single molecule of VP2 or VP3 is tightly attached
to each pentamer at its inward facing cavity, through a region
close to the C-terminus of VP2/3 [3,4]. These and other findings
indicate that VP15VP2/3 is the building block for SV40 capsid
assembly. VP1 has a jelly-roll b-barrel structure [1,5], with
extending N-terminal arm, that carries the DNA-binding domain
[6], and ,60 amino acids long C-terminal arm.
The icosahedral capsid of members of the polyomaviradae
family is built of 72 identical VP1 pentamers [7]. 12 of those are
surrounded by 5 pentamers each (‘pentavalent pentamers’) and the
other 60 by 6 pentamers each (‘hexavalent pentamers’). The
puzzle how the variability in contacts between the identical
building blocks is achieved has been solved by the elegant X-ray
crystal structure study, which has shown that the pentamers are
tied together via the long flexible C-arms [5]. Five C-arms extend
from each pentamer and insert into the neighboring pentamers in
three distinct kinds of interactions. It has been recently shown, by
in vitro assembly studies, that the correct inter-pentamer bonding in
both polyomavirus and SV40 is facilitated by host chaperones [8].
The capsid is stabilized by Ca
++ and S-S bonds [1]. There are
two cation binding sites per VP1 monomer, which appear to
stabilize the capsid by ‘‘locking’’ the invading C-arm [1]. Mutations
in putative Ca
++ binding acidic residues suggested that Ca
++
coordination is important for both virus assembly and for early
stages in the infection process [9]. S-S bonds has been observed
between monomers of neighboring pentamers, at Cys 104 [1].
Early studies on SV40, performed by a number of groups,
revealed that assembly occurred inside the nuclei, and consistently
showed that it occurred by addition and organization of the
capsomers around the viral minichromosome, rather than by
incorporation of DNA into pre-formed capsids (for representative
references see [10,11,12,13,14,15]). Importantly, empty SV40
particles present in standard virus stocks were demonstrated to be
the dissociation products of immature virus rather than an
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gradient sedimentation experiments indicated that viral morpho-
genesis proceeded via a series of intermediates: 100S replicating
chromatinR75S intermediateR200S pre-virionsR240S mature
virions. The 75S nucleoprotein complex was found to rapidly
convert to 200S pre-virions, with a full complement of capsid
proteins. Assembly intermediates with partial capsids were only
seen in studies with virions mutated in VP1 [16,17]. Notable
assembly intermediates also accumulated in virions with mutations
at the amino-terminus of the T-antigen gene [18], in a region
demonstrated to encode for the co-chaperone J-domain [19],
supporting the requirement for chaperones. In addition, rearran-
gement of nucleosomes around the SV40 genome, driven by the
capsid proteins, was shown to be a prerequisite for assembly
[20,21].
All three capsid proteins were found to bind DNA non-
specifically [6,22] at a high affinity. This raised the question how
they recognize the viral minichromosome within the nucleus, in
the presence of a large excess of cellular chromatin. Our studies
indicated that specific recognition of the SV40 minichromosome is
achieved via Sp1 bound at the SV40 encapsidation signal ses
[23,24]. Sp1 is a 95 kDa mammalian transcription factor,
containing a zinc finger protein motif, by which it binds directly
to GC-motifs on the DNA and enhances gene transcription [25].
In SV40 Sp1 binds to the GC-boxes, which are part of the
encapsidation signal ses, within the regulatory region of the
genome.
Our genetic and biochemical studies indicated that Sp1 recruits
the capsid proteins to the viral minichromosome, forming an Sp1-
VP15VP2/3-ses recruitment complex [4,26]. Furthermore, we
found that binding of the VP15VP2/3 complex to ses in the
presence of Sp1 led to turnoff of both early and late genes [26],
thus acting in regulating the transition from replication and
transcription to assembly. Sp1 was not found in mature virions
[27], indicating that before assembly it was displaced from the
viral genome, facilitating nucleosomal reorganization and con-
densation of the minichromosome [20,21].
Icosahedral capsid assembly must be an efficient, high fidelity
process. The final product is a topologically closed, stable sphere-
like particle. Theoretical considerations, supported by experimen-
tal results on HBV capsid assembly, suggest that assembly is
initiated by a nucleation center, in a slow, rate limiting step
[28,29]. This ensures an extremely robust assembly reaction
regardless of protein concentration, avoiding ‘kinetic traps’, which
occur when there are too many assembly initiation events and
insufficient level of free subunits to allow them to reach completion
[30]. In SV40, the Sp1-VP15VP2/3-ses recruitment complex (or
multiple of those) that binds at a very high affinity to a specific site
of the SV40 genome, ses, most likely also functions as the
nucleation center for assembly. We propose that the 75S species,
the only intermediate seen in the early in vivo assembly studies,
which contains chromatin with a small amount of VP1 and VP2/3
[15,31,32], represents the viral genome with the nucleation center
attached.
Our recent EM studies, using a VP1 mutant deleted in the C-
arm that can bind DNA but cannot assemble, have shown that in
vitro multiple capsomers bind around single DNA molecules at
random locations [27]. We have proposed that this occurs also in
vivo, after the nucleation center is formed, increasing local
capsomer concentration and facilitating rapid, concerted assembly
reaction. We have further suggested that these additional
capsomers bind at a lower affinity than the nucleation center,
allowing their rearrangement around the minichromosome, as
required for capsid geometry.
Recombinant VP1 of polyomaviruses contain the information
for self-assembly. VP1 of various members of the polyomaviradae
family, produced in E. coli [33,34] or in insect cells
[35,36,37,38,39] spontaneously assembles into polymorphic vi-
rus-like particles (VLPs) of different sizes. Recently it has been
demonstrated that adding chaperones to the assembly reaction
leads to a high fidelity (albeit inefficient) assembly of particles of
uniform size and shape [8].
We previously reported that SV40 VLPs produced in insect cells
were capable of incorporating plasmid DNA in a simple mixing
reaction [40]. We showed that intact supercoiled DNA molecules
were packaged within the particles, that the particles were
infectious and that the transmitted DNA was a biologically active
in gene expression and replication. VP2 and VP3 did not enhance
their assembly and/or infectivity, suggesting that the VP1 shell is
sufficient for these functions. Here we have established an
assembly reaction that more closely mimics the in vivo process,
whereby capsomers assemble around DNA, under physiological
conditions, in the presence of as yet unidentified host-cell factors.
The results show very high cooperativity of VP1 in the reaction
and support the model described above, in which multiple VP1
pentamers first bind to the DNA, which becomes compacted and
serves as a scaffold for assembly.
RESULTS
The experimental system developed here was based on disassem-
bly of VLPs produced in Sf9 cells and their reassembly in presence
of supercoiled plasmid DNA. As a VP1 source we used nuclear
extracts derived from Sf9 cell infected with recombinant
baculovirus expressing VP1. To facilitate functional assay of the
assembly process we used a reporter plasmid carrying the luc gene.
A quantitative assay based on luc activity of infected cells, which
measures not only particle formation but also their infectivity, has
been used throughout the experiments below.
The disassembly-assembly reaction
SV40 was previously shown to disassemble into VP1 pentamers in
the presence of reducing and chelating agents [37,41,42]. We have
found that the VLPs are significantly less stable than the virus. In
contrast to wild type SV40, which required both DTT and EGTA
for disassociation, VLPs consisting of VP1, VP2 and VP3
completely dissociated by incubation with either DTT or EGTA
alone [37]. For the present study we have chosen to dissociate the
particles by DTT and to avoid the use of chelating agents, as they
might interfere in subsequent steps of DNA binding and assembly.
As observed by EM, the VLPs start dissociating at 5 mM DTT
and at 15 mM they are no longer visible (not shown).
As the DNA-binding domain of VP1 is at the internal face of the
capsid, we have anticipated that the pentamers would assemble
around the DNA. Based on this rationale, the disassembly-
assembly reaction has been planned in 3 steps: Step A, dissociation
of the VLPs in DTT; step B, the addition of DNA with
concomitant dilution of the DTT to allow VP1-DNA binding
and assembly; and step C, stabilization of the re-assembled
capsids. The complete reaction is described in detail in Materials
and Methods.
The requirements for the reaction are summarized in Table 1.
The reaction yield, measured as luc-transducing units (TU), was
highly reproducible, as demonstrated by the small standard error
of repeated experiments. As expected, control experiments showed
absolute requirement for VP1 and DNA. As an additional control
we used a mutant VP1, VP1DC, with a deletion of the entire
carboxy terminal arm that links between pentamers. As the
Cooperativity of SV40 VP1
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mutant retains DNA-binding activity but cannot assemble into
capsids [43]. As seen in Table 1, replacement of VP1 by VP1DC
completely abolished packaging. The requirement for DTT was
also absolute, and its presence was required at the dissociation
step, A (Table 1). Dilution of the added DTT in the second and
third steps allowed the particles to re-assemble around the DNA
molecules. The particles were stabilized at pH 5.2.
We tested the assembled particles for DNA protection by
extensive DNase I digestion, after raising the pH from 5.2 to ,8,
as described in Materials and Methods. The results consistently
demonstrated that this treatment did not reduce the yield of luc-
transducing nanoparticles, indicating that the packaged DNA was
DNase resistant.
The reaction requires cellular factors
The optimal temperature for the reaction is 37uC and optimal salt
concentration was 160 mM monovalent salts (Fig. 1A,B) suggest-
ing an enzymatic activity, presumably provided by the cellular
extracts. The optimal salt concentration may also represent
a balance between the need, on one hand, to stabilize the particles
(VLPs are stabilized at 1 M NaCl [33]), and on the other hand to
allow protein-DNA interaction, which are destabilized at a high
ionic strength. The requirement for ATP and Mg
++ (Table 1) is
also consistent with the participation of chaperones.
VLPs were purified prior to packaging by sucrose gradient
centrifugation from 5 different samples of nuclear extracts (see
Fig. 2A for a typical purified preparation). Packaging experiments
consistently showed that purification abolished packaging activity
(Table 1), indicating that cellular factors were required. Packaging
with VLPs isolated from the medium of infected Sf9 cells 5 days
post infection, when the cells were lysed, was only ,1% of the
standard reaction with nuclear extracts.
In addition we found that a sharp peak of packaging activity was
obtained in nuclear extracts harvested 72 hours post infection
(Fig. 2C), while the level of VP1 was constant at 48–96 hours
(Fig. 2B,C). This finding suggested that factors in the nuclear
extracts other than VP1 participate in assembly.
The nuclear extracts used for the packaging reaction contained
significant amounts of Sf9-derived cellular RNA and DNA. RNase
treatment following the addition of DTT facilitated removal of
free RNA as well as RNA captured within VLPs (data not shown).
Consistent with previous findings of others [44,45], we also found
that cellular DNA begins degrading 4 days post infection. At the
time of harvest, 3 days post infection, it was high molecular
weight, not likely to be packaged within VLPs.
Stoichiometry of the reaction and cooperativity of
VP1
The reaction yield increased linearly with increasing DNA input,
reaching an optimum at 1 mg DNA per reaction (Fig. 3A). Higher
DNA concentrations were inhibitory, maybe because they
sequestered VP1 pentamers and did not allow the assembly
intermediates to go to completion. When VP1 concentration was
varied the reaction was sigmoid, indicating cooperativity, and
reached saturation at 5 mg VP1 per reaction (Fig. 3B). The optimal
VP1:DNA ratio on a weight basis, 5:1, corresponded to a 1:1
capsid to DNA molar ratio (MW of a VP1 capsid is ,15 Mda ,
and of a 5 Kbp DNA molecule is ,3 Mda). At high VP1
concentrations the reaction leveled off. It is possible that excess
VP1 molecules assembled into empty particles.
Different nuclear extract preparations contained variable levels
of VP1. This is not surprising, since VP1 level depends on
a number of biological factors that are not fully controlled. Taking
advantage of this variability we analyzed 14 different nuclear
extract preparations with different VP1 contents. The results
(Fig. 3C) showed dramatic sigmoid correlation between reaction
yield and VP1 content. Extracts that contained less than 1 mg/ml
VP1 had very low activity. Some of the data points were
superimposed, therefore only 11 data points are seen in the
graph. These data were analyzed according to the Hill equation,
which provides a way to quantify cooperativity of a reaction [46].
The resulting Hill coefficient was 5.860.6 (Fig. 3D), suggesting
that under the present conditions (in presence of nuclear factors)
cooperativity was between at least 6–7 partners, presumably VP1
pentamers. For comparison, the Hill coefficient of the cooperative
binding of 4 O2 molecules to the hemoglobin tetramer is 2.8
[46,47].
Characterization of the DNA-containing
nanoparticles
The reaction products were analyzed by equilibrium sedimenta-
tion in a CsCl density gradient (Fig. 4). The peak of transducing
units coincided with the peak of DNA (analyzed by real-time PCR)
at a density of 1.35 g/cm
3, like wild type SV40. The fraction at the
peak contained 3.4 mg DNA, corresponding to 6610
11 plasmid
molecules or 6610
11 packaged nanoparticles. The same fraction
contained 1.8610
6 transducing units (TU). These data translate to
transduction efficiency of 1 per ,3610
5 nanoparticles. For
comparison, the infectivity ratio of wild type SV40 is 1:200 to
1:500 ([48] and our unpublished results). Thus the nanoparticles
are ,1,000 fold less infective than wild type SV40.
Table 1. Composition of the packaging reaction.
......................................................................
Composition
a Titer610
3 TU/ml
b Activity (%)
Complete reaction 1,4996191 (5) 100
-VP1 control 0 (4) 0
-DNA control 0 (5) 0
VP1-DC 0 (2) 0
Purified VLPs 0 (5) 0
Step A -DTT 261 (3) 0.1
-RNase 41629 (3) 2.7
-DTT&RNase 865 (3) 0.5
Step B -ATP (5 mM) 7806228 (3) 52.0
-Mg
++ (5 mM) 7846131 (3) 52.3
-Glycerol (8%) 9836218 (3) 65.5
100 mM salt 3686126 (3) 24.5
Step C pH 5.2 1,4996191 (5) 100
-Ca
++ (1 mM), pH 5.2 1,5196204 (3) 101
pH 7.0 5566115 (3) 37.0
-Ca
++ (1 mM), pH 7.0 835 (1) 55.7
Time of DTT
addition
at step A 1,5896431 (5) 100
at step B 3426211 (5) 21.5
at step C 25621 (5) 1.5
after step C 1067 (5) 0.6
aFinal concentration of the reagents in the reaction mixture at each step is
shown in parentheses.
bAverage6S.E. The titer is shown as luciferase transduction units. The number
in parenthesis represents the number of repeated experiments.
doi:10.1371/journal.pone.0000765.t001
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appeared as a single protein (VP1) band on Coomassie-stained (not
shown). Western analysis demonstrated that the particles did not
contain histone octamers, as detected by antibody against H3
(Fig. 5A, lane 2). Note that H3 histone was detected in the nuclear
extract (lane 1) and in wild type SV40 (lane 3). Analysis by VP1
antibody showed that equal amounts of VP1 were loaded on the
gel (Fig. 5B). The packaged DNA was released from the purified
particles by alkaline treatment and analyzed by electrophoresis. It
appeared as a single distinct DNA band (Fig. 5C), suggesting that
complete molecules were packaged.
Under electron microscopy the purified particles appeared well
dispersed and of uniform shape and size (,45 nm, Fig. 6B), like
wild type SV40 (Fig. 6C). The purified particles appeared to be
more permeable to the stain than wild type SV40, most likely
because of the absence of histone proteins, which were shown to
occupy much of the space within the particles [49]. It may be
noted that prior to packaging many of the VLPs were smaller
(Fig. 6A), presumably T=1 and T=3 structures. Thus it appears
that the present reaction conditions direct the formation of T=7
particles.
DISCUSSION
This study demonstrates that capsomers can assemble in vitro
around DNA, in a reaction that requires host factors. The particles
assemble at a stoichiometry of one DNA molecule per capsid,
forming uniform particles of the same size, shape and density in
CsCl as wild type SV40. Convincing evidence for genuine
assembly, rather than non-specific association that protects the
DNA from DNase I, is also provided by the finding that VP1-DC
mutant has not been active in this reaction. This mutant VP1
retains its DNA-binding domain (localized at the N-terminus) and
full DNA-binding activity, while it cannot assemble into capsids
[43]. Its inability to package argues against non-specific VP1-DNA
interaction. True DNA packaging is also suggested by the 1:1
stoichiometry of the reaction and by the supercoiled state of the
packaged DNA.
How does the present assembly reaction proceed? Our data
suggest the following scenario (see Fig. 7): The addition of DTT to
nuclear extracts leads to disassembly of the VLPs into VP1
pentamers and/or pentamer-clusters (Step A). Following the
addition of supercoiled DNA we propose that a number of such
units bind, in a rapid reaction, along each DNA molecule (Step B),
Figure 1. Parameters affecting the in vitro packaging reaction. Effect of temperature (A) and concentration of monovalent salts (B) present during
the re-association reaction (step B) on the yield, measured as titer of luc transducing units.
doi:10.1371/journal.pone.0000765.g001
Figure 2. The reaction requires cellular factors. A–VLPs were purified on sucrose gradient from nuclear extracts harvested on day 3. M-molecular
weight marker; VLPs–purified VLPs used in the packaging experiment (Table 1). B-Nuclear extracts were harvested from infected Sf9 cells at different
time points after infection, as designated on top, and analyzed by SDS-PAGE and Coomassie-blue staining. M-molecular weight marker; Mock-nuclear
extract of Sf9 cells infected with wild type baculovirus; SV40-nuclear extract of CV1 cells infected with wild type SV40; BSA-1 mg BSA, a standard for
band intensity. C-Activity of the nuclear extracts shown in part B. #-Packaging activity measured as titer (left ordinate); %-VP1 level estimated from A
(right ordinate).
doi:10.1371/journal.pone.0000765.g002
Cooperativity of SV40 VP1
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[27]. This increases the local concentration of VP1, facilitating
concerted assembly, as seen by the high VP1 cooperativity and
Hill coefficient. We predict that DNA-binding is a rapid reaction,
and assembly is the rate-limiting step. It is possible that some
pentamer-pentamer associations occur prior to DNA-binding, and
that pentamer-clusters, rather than single pentamers, serve as
building blocks for assembly. However, the possibility that the
capsids assemble before they bind DNA is unlikely in view of the
absolute requirement for DTT at the beginning of the reaction
(Table 1). Thus the DNA appears to function as a scaffold for
capsid formation, as described for CCMV [50]. For recombinant
VP1 of members of the polyomaviradae family the DNA scaffold is
however not obligatory, as we and others have observed that it can
assemble into empty capsids in the absence of DNA
[33,34,35,36,37,38,39].
Our previous studies have suggested that in vivo, as the infection
cycle progresses and the level of capsid proteins in the nucleus
becomes sufficiently high, they are recruited by Sp1 to ses, turning
off the early and late promoters and forming the assembly
nucleation center [26]. We propose that formation of the
nucleation center is followed by binding of multiple capsomers
to the minichromosome at a lower affinity. They bind at quasi-
random locations, as only part of the DNA is accessible depending
on nucleosomal configuration. This binding increases local
capsomer concentration, facilitating the highly cooperative
assembly reaction as seen here. Following the equilibrium model
for virus assembly [28], we suggest that after the initial binding of
VP1 pentamers to DNA, interpentameric bonding form and
dissociate in a series of equilibrium reactions until correct
configuration is achieved and the icosahedral shell is completed.
During this process the DNA is compacted, VP1 pentamers
rearrange around the molecule as required for capsid geometry
and form the proper interpentameric links, out of three different
types found in the mature virion [1]. Stability of the icosahedral
shell with its low free energy state drives the reaction to
Figure 3. Cooperativity of VP1 in the reaction. Effect of substrate concentration on the reaction yield. A–DNA; B–VP1. The amounts used per
reaction, as described in Materials and Methods, is indicated. C-Fourteen different batches of nuclear extracts were assayed for packaging activity.
Only 11 distinct data points are seen because of overlap of some of the data points. D-Calculation of Hill coefficient from the same set of data as in C.
Y is the fraction of fully assembled VP1, measured as TU.
doi:10.1371/journal.pone.0000765.g003
Cooperativity of SV40 VP1
PLoS ONE | www.plosone.org 5 2007 | Issue 8 | e765completion. In the present reaction the capsids containing DNA
are stabilized at a low pH (Fig. 7 Step C).
Could this in vitro assembly reaction serve for further studies on
in vivo assembly? The process described here differs from in vivo
assembly of SV40 primarily by the absence of VP2 and VP3 and
the use of naked plasmid DNA rather than a minichromosome.
Nevertheless, the findings obtained from this simplified assembly
system are in full agreement with in vivo studies. First, the reaction
represents assembly around the SV40 genome, rather than
insertion of DNA into preformed shells. Second, our data account
for the inability of previous investigators to isolate partially
assembled intermediates from infected cells, except when mutant
VP1 [16,17,31,51] or mutant T-antigen, presumably defective in
DnaJ chaperone function [18,32], were used. Furthermore, the
requirement for host factors, for physiological conditions (temper-
ature, pH and salt concentration) and for ATP and Mg
++ is
consistent with the participation of chaperones in this in vitro
system. A number of investigators have recently reported, based
on studies with mutant viruses of both polyoma and SV40, that
VP2 and VP3 are not required for the assembly process in vivo, but
rather for infectivity, egress and for the transport of the viral
genome to the nucleus [52,53,54,55]. Consistent with these data
the particles produced here are significantly less infective than wild
type SV40.
What is the contribution of cellular factors? Recently, the
participation of chaperone machinery in assembly in vitro of empty
particles of polyomavirus and SV40 (in the absence of DNA) has
been clearly demonstrated [8]. Specifically those studies suggested
that chaperones facilitate the fomration of uniform T=7
nanoparticles, since in their absence polymorphic particles, mostly
of smaller size, were formed. Involvement of chaperones in the
present assembly reaction is suggested by the temperature and salt
profiles of the reaction and the requirements for ATP and Mg
++.
In addition, our recent data (Abd-El-Latif and Oppenheim,
unpublished) suggest the participation of topoisomerases, as the
reaction yield was affected by the addition of Etoposide , a topo II
inhibitor. Topo II most likely functions in DNA compaction,
facilitating its packaging inside the particles. Indeed detailed EM
studies demonstrated that in the absence of host factors, when
purified capsids of polyoma [56] or BK [39] were used, the DNA
Figure 4. Equilibrium sedimentation in CsCl gradient. The reaction products, 2 ml, were fractionated on a CsCl density gradient in stabilization
buffer at pH 5.2 (Materials and Methods). VP1 was analyzed by Coomassie and Bradford, DNA by real-time quantitative PCR and luc TU as described in
Materials and Methods.
doi:10.1371/journal.pone.0000765.g004
Figure 5. Analysis of the particles. A,B-Proteins were separated by elecrtrophoresis in Tricine buffer on 16% polyacrylamide gel. Western blotting
was performed with polyclonal antibody against histone H3 (Upstate) (A) and against VP1 (B). M–size marker; 1–Nuclear extracts used in the
packaging reaction; 2–In vitro assembled particles, fraction 9 of Fig. 4. 3–wild type SV40. C-Analysis of the packaged DNA. Particles purified by
ultrafiltration were treated with Tris base (200 mM) in presence of 25 mM EGTA and 25 mM DTT for 1 hr at 37uC. DNA was extracted by phenol-
chloroform treatment in presence of 1% SDS, and analyzed by Southern blotting with pGL3-control as a probe.
doi:10.1371/journal.pone.0000765.g005
Cooperativity of SV40 VP1
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rather than being packaged inside.
Additional investigations are needed for full in vitro recapitula-
tion of the assembly process, in presence of all three capsid
proteins and the viral minichromosome. Nevertheless the present
in vitro reaction facilitates an insight into the assembly reaction, and
will serve for further biochemical and biophysical studies using
both wild type and mutant VP1, and as a basis for identification of
participating host factors.
Finally, the present reaction can be utilized to produce DNA-
containing nanoparticles as a safe gene therapy vector. As the DNA
used here is propagated in bacteria, there is no need for the SV40
ori. The absence of competing cellular chromatin relieves the
requirement for the packaging signal ses and for Sp1. Thus plasmids
withoutany SV40 sequencesmaybepackaged,providing thevector
with additional safety margin [57]. Furthermore, the absence of
histones provides space and facilitates packaging of significantly
larger plasmids (plasmids as large as 17 kb were shown to be
packaged [57]), another significant advantage for gene therapy
vectors. Together with the development of procedures for
purification and concentration, we have demonstrated efficient
gene delivery of the luc reporter gene, constructed as described here,
to the liver in mice (Fig. 1C in ref. [58]). Importantly for gene
therapy, we and others have found that SV40 vectors do not elicit
cellular immune response [58,59]. Potential applications and merits
of in vitro constructed SV40-based vectors for gene therapy have
been recently discussed [60,61].
MATERIALS AND METHODS
Cell cultures and media
Spodoptera frugiperda (Sf9) cells were grown at 27uC in serum-free
Bio-insect medium containing glutamine, penicillin, streptomycin
and amphotericin (Biological Industries, Israel). COS-1 cell-line is
a derivative of CV1 (ATCC # CCL70) harboring the SV40 T-
antigen gene [62]. COS-1 cells were cultured in high glucose
Dulbecco’s modified Eagle’s medium containing glutamine,
penicillin, streptomycin, and 10% FBS.
Production of recombinant VP1 and DNA
Recombinant baculovirus expressing VP1 (Swiss-Prot P03087,
PDB 1SVA) from the polyhedrin promoter [37] were propagated
in Sf9 cells. High titer virus stocks (.10
9 pfu/ml) were used to
infect logarithmic cultures of Sf9 cells, at moi 10, for VP1
production. Seventy two hours post infection the cells were
harvested by centrifugation and nuclear extracts were prepared by
a procedures adapted from Schreiber et al. [63]. Nuclear extracts
were stored in aliquots at 280uC. The VP1DC mutant is deleted
for the complete 65 amino acid C-arm and carries a His tag at its
carboxy end [27].
Plasmid pGL3-control (Promega cat # E1611), which carries
the luc reporter gene expressed from the early SV40 promoter, was
used for the in vitro packaging experiments. It was prepared in E.
coli and purified using Qiagene EndoFree Plasmid Purification
Giga kits.
Protein analysis
Total protein was determined by the Bradford assay. The amount
of VP1 in nuclear extracts was estimated from Coomassie-stained
SDS-PAGE by comparing band intensities with known amounts of
BSA.
In vitro assembly reaction
Assembly reactions were conducted in 3 steps. A typical reaction
was carried in microtubes as follows: In step A, 5 ml Sf9 nuclear
extract, containing ,5 mg of VP1 were treated with DTT to a final
concentration of 15 mM, and with 10 mg RNase, in a final volume
of 10 mla t3 7 uC for 20 minutes. In step B the DNA mix
(containing 1 mg pGL3-control DNA, 10 mM ATP, 20 mM
Figure 6. Structure of the nanoparticles. Transmission electron
microscopy pictures of (A) VLPs, (B) in vitro packaged nanoparticles,
and (C) wild type SV40. Samples were adsorbed onto formvar-carbon-
coated copper grids and stained with 1% sodium phosphotungstate,
pH 7.0. The samples were viewed in a Philips CM-12 electron
microscope, using a voltage of 100 kV, and photographed at
a magnification of 53,0006.
doi:10.1371/journal.pone.0000765.g006
Figure 7. A model for the in vitro assembly reaction. The addition of DTT to nuclear extracts (A) leads to disassembly of the VLPs. Following the
addition of supercoiled DNA (B) pentamers bind along each DNA molecule. This increases the local concentration of VP1, facilitating concerted
assembly. Reassembly may be facilitated by presence of chaperones in the nuclear extracts. Assembly is accompanied by DNA condensation,
presumably via the action of topo II. In Step C the capsids are stabilized at pH 5.2.
doi:10.1371/journal.pone.0000765.g007
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10 mM MgCl2, 16% Glycerol and 0.08% NP-40, in a final
volume of 10 ml) was added to the treated nuclear extracts (step A),
and the reaction was further incubated at 37uC for 1 hour. Note
that at step B the DTT was diluted 2 fold and salt concentration
brought to 160 mM. For step C the packaging reaction was kept
on ice overnight after the addition of 10 ml stabilization buffer
(150 mM sodium acetate buffer pH 5.2, 3 mM CaCl2 (final
concentration 1 mM), 120 mM KCl and 40 mM NH4Cl, keeping
the salt concentration at 160 mM), bringing the total volume to
30 ml. The mixture was treated with 0.5 unit of DNase I (Promega)
on ice for 10 minutes. The reaction was stopped by adding 10 ml
of chloroform, the mixture was vortexed, separated by centrifu-
gation and the assembled particles were recovered in the aqueous
layer. The reaction was upscaled 1,000 fold in 50 ml tubes without
loss of activity.
Quantification of the reaction yield
The reaction yield was measured by titrating infectivity of the
nanoparticles as luc–transducing units (TU) in COS-1 cells, using
an end-point dilution assay [58]. COS-1 cells were infected by
serial dilutions of the reaction mixture, LUC activity was
measured 2 days later, the data plotted and TU titer was
determined by extrapolation to null LUC activity. Titers obtained
by this method were consistent with titers measured as infective
centers, scored by in situ hybridization of infected CMT4
monolayers [24].
DNase resistance of the packaged DNA
The reaction mixture was routinely treated with DNase I before
measuring the titer yield. However during the course of this study
the pH of the stabilization step, just prior to DNase treatment, was
changed from 7.0 to 5.2, which is not favorable for DNase I
activity. Therefore DNase resistance of the packaged DNA was re-
tested after the pH was raised to ,8 with 1 M Tris base, and Mg
++
was added to a final concentration of 10 mM. DNase I resistance
was tested by the addition of 0.5 units per reaction (containing
1 mg pGL3-control DNA) and incubation for 30 min at 25uC.
Reconstruction experiments demonstrated that 1 mg of plasmid
DNA added to a mock reaction mixture was extensively digested
under these conditions by 20 min.
Equilibrium sedimentation in a CsCl gradient
2 ml of the reaction products were centrifuged in CsCl in
stabilization buffer (r=1.34 g/cm
3) at 40,000 rpm, 4uC for
40 hrs. Fractions were collected from the bottom, refractive index
was measured and the fractions were dialyzed against stabilization
buffer. Quantitative real-time PCR was performed using SYBR
green in a Light Cycler machine (Roche), with primers flanking
the SV40 polyA signal generating a 177 bp PCR fragment (SV40
coordinates 2533-2710): 59-ACATTGATGAGTTTGGACAAA-
CCAC-39 and 59-CCCCTGAACCTGAAACATAAAATG-39.
Purification and concentration of the nanoparticals
For some experiments the particles were purified and concentrated
,30 fold by stirred-ultrafiltration under Argon using XM300
membrane (Millipore). This step was performed following DNase I
and Chloroform treatment. The concentrate was resuspended in
PBS (half the original volume) and re-filtered 3 additional times. In
later experiments we found that using saline instead of PBS
substantially enhanced viability of the assembled particles
(measured as infectivity) during prolonged storage at 220uC.
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